Biomedical Development Corporation
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Biomedical Development Corporation sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Biomedical Development Corporation: 8 sponsored US clinical trials, none currently recruiting.
Biomedical Development Corporation sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cystitis, with 1 trials.
Upper-quartile sponsor footprint
Biomedical Development Corporation sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
mHealth for Patient Self-Management of Opioid Use Disorder
NCT03633929
Dose-Response Study of Iocide Oral Rinse
NCT01103102
Treatment and/or Prevention of Urinary Tract Infections
NCT00801021
Exploratory Study of Iocide Oral Rinse in a Diabetic Population
NCT00801164
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
NCT00612963
Pilot Efficacy Study to Treat Gingivitis
NCT00391547
New Topical Treatment for Continued Pain After Shingles
NCT00566904
Novel Topical Treatment of Hand Dermatitis (Eczema)
NCT00614289
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 2 |
Therapeutic Areas
How the Biomedical Development Corporation early-phase archive is shaped
8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Cystitis (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Biomedical Development Corporation: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Biomedical Development Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Biomedical Development Corporation page
8 registered trials is a research-attention snapshot, not an endorsement of Biomedical Development Corporation or any single study.
- None of Biomedical Development Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cystitis is the condition Biomedical Development Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cystitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Biomedical Development Corporation pipeline card: 8 registered trials from official public datasets.Report a data error.